WHO ICTRP trial
Dexmedetomidine Sedation for Awake Fibreoptic Bronchoscopy
ACTRN12608000304336 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Not Recruiting
Key facts
| Trial ID | ACTRN12608000304336 |
|---|---|
| Public title | Dexmedetomidine Sedation for Awake Fibreoptic Bronchoscopy |
| Scientific title | Feasibility and Safety of Dexmedetomidine Sedation for Patients presenting for Awake Fibreoptic Bronchoscopy |
| Primary sponsor | Keat Lee |
| Secondary sponsors | Ruari Orme |
| Registry | Australian New Zealand Clinical Trials Registry (ANZCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 3 |
| Countries | Australia |
| Conditions | Safety and Feasibility of Dexmedetomidine Sedation for Awake Fibreoptic Bronchoscopy; Safety and Feasibility of Dexmedetomidine Sedation for Awake Fibreoptic Bronchoscopy;Anaesthesiology - Anaesthetics |
| Interventions | Dexmedetomidine sedation as an intravenous infusion to obtain sedation. Initial bolus of 0.5mcg/kg over 10 minutes followed by an infusion of 0.2-0.7mcg/kg/h, titrating to a Ramsay Sedation Score of 4 during the procedure. This infusion… |
| Registration date | Jun 20, 2008 |
| Target size | 100 |
| Secondary IDs | nil known |
| Registry page | anzctr.org.au |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: